Sign In
Pharma
Biocon Biologics gets EMA approval to produce Bevacizumab
Biocon Biologics gets EMA nod to manufacture cancer drug in India
Technology
Biocon Biologics gets USFDA nod for Eylea
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Eco Buzz
Eris acquires Biocon’s branded formulations
Biocon Biologics inks license pact with Janssen for biosimilar product
Industry
Biocon Biologics completes integration of biosimilars biz
Biocon Biologics' subsidiary of Biocon Limited gets EU certification
Biocon Biologics appoints Umesh as CCO
Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
